Politics gains heat over approval of Corona vaccine | Hoonkar

During the press conference, Bharat Biotech CMD Ella hailed the decision of the Indian drug regulator to approve Covaxin for emergency restricted use and termed it as a giant leap for innovation and novel product development in India. Ella also said that the firm has 20 million doses ready and is confident to manufacture 80 million more by July.